KEYTRUDA (pembrolizumab) Patient Assistance Program
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
- Medicare Part D Patients Accepted
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Keytruda (pembrolizumab) is FDA-approved across more than 30 cancer indications including melanoma, non-small cell lung cancer, head and neck cancer, classical Hodgkin lymphoma, urothelial carcinoma, gastric cancer, colorectal cancer (MSI-H/dMMR), triple-negative breast cancer, cervical cancer, hepatocellular carcinoma, renal cell carcinoma, endometrial cancer, and many others. It is a PD-1 checkpoint inhibitor given as IV infusion every 3 or 6 weeks.
- Without assistance, Keytruda costs commonly run approximately $11,000–$13,500 per dose (every-3-week dosing), with annual costs commonly $190,000–$235,000+.
- Through AffordMyPrescriptions, qualifying patients can access Keytruda for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- There is no biosimilar of Keytruda in the U.S. as of 2026. Other PD-1/PD-L1 checkpoint inhibitors include Opdivo (nivolumab), Tecentriq (atezolizumab), Imfinzi (durvalumab), Bavencio (avelumab), Libtayo (cemiplimab), and Jemperli (dostarlimab).
What Is Keytruda Prescription Assistance Program?
Pharmacy Price Comparison
- Without assistance, Keytruda costs roughly $11,000–$13,500 per dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$12,800/dose | Save substantially |
| CVS Pharmacy | ~$13,500/dose | Save substantially |
| Walmart | ~$11,500/dose | Save substantially |
| Costco | ~$11,200/dose | Save substantially |
Specialty Pharmacy | ~$12,000/dose | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Keytruda Prescription Program?
The Patient Assistance Program is free to apply for and provides Keytruda at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Keytruda:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $11,000–$13,500 per dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Kesimpta assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Keytruda Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Keytruda:
Keytruda (pembrolizumab) is a humanized monoclonal antibody that blocks PD-1 (programmed cell death protein 1) — a checkpoint receptor on T-cells that, when activated by tumor cells, suppresses anti-tumor immunity. By blocking PD-1, Keytruda ‘releases the brakes’ on the immune system and allows T-cells to attack cancer cells. It is FDA-approved across many cancer types.
How Keytruda Works:
Cancer cells often exploit the body’s immune checkpoints by upregulating PD-L1, which activates PD-1 on T-cells and effectively turns off the immune response against the tumor. Keytruda works as a humanized monoclonal antibody that binds to PD-1 on T-cells, preventing PD-L1 and PD-L2 from activating it. This action releases the brakes on the immune system, allowing T-cells to recognize and attack tumor cells for durable anti-tumor responses. While it can produce long-lasting remissions, responses vary, and biomarkers like PD-L1 expression, MSI-H/dMMR status, or high tumor mutational burden help predict its effectiveness.
Form and use:
Keytruda is administered as an intravenous infusion, typically delivered over a period of 30 minutes. For most adult indications, the standard dosing regimen is either 200 mg every 3 weeks or 400 mg every 6 weeks. Pediatric dosing is weight-based at 2 mg/kg every 3 weeks, up to a maximum dose of 200 mg. Treatment is generally continued until disease progression occurs, unacceptable toxicity develops, or for up to a total of 24 months in specific indications.
Generic availability:
As of 2026, there is no biosimilar version of Keytruda available in the United States. Other PD-1 and PD-L1 checkpoint inhibitors are available on the market, including Opdivo, Tecentriq, Imfinzi, Bavencio, Libtayo, and Jemperli. Each of these alternative therapies features a different set of FDA-approved indications. However, the clinical differences between targeting PD-1 versus targeting PD-L1 remain modest in most direct comparisons.
Warnings:
Keytruda carries significant warnings for immune-mediated adverse reactions that can affect nearly any organ system in the body. These reactions include pneumonitis, colitis, hepatitis, nephritis, endocrinopathies, severe dermatologic reactions, myocarditis, and neurological conditions like encephalitis. Additionally, it poses risks for solid organ transplant rejection, infusion reactions, and embryo-fetal toxicity. Complication rates are also higher when Keytruda is combined with CTLA-4 inhibitors like Yervoy.
FAQ (Frequently Asked Questions)
How Much Does Keytruda Cost Without Insurance?
Keytruda costs approximately $11,000–$13,500 per dose (every 3 weeks), with annual costs commonly $190,000–$235,000+. Through AffordMyPrescriptions, qualifying patients receive Keytruda at no medication cost — our $69.95 monthly fee covers full advocacy and program management.
What Is A Checkpoint Inhibitor?
Checkpoint inhibitors are immunotherapy drugs that block proteins that normally limit immune responses — ‘releasing the brakes’ on the immune system so it can attack cancer. PD-1 inhibitors (Keytruda, Opdivo, Libtayo) and PD-L1 inhibitors (Tecentriq, Imfinzi, Bavencio) act on the PD-1/PD-L1 pathway. CTLA-4 inhibitors (Yervoy) act on a different checkpoint. Some patients have dramatic, durable responses; others don’t respond.
Do I Need Biomarker Testing Before Keytruda?
Depending on the cancer type, yes. For some indications (e.g., first-line NSCLC monotherapy), PD-L1 expression testing on tumor tissue is required. For some indications (colorectal, endometrial cancers), MSI-H/dMMR status is required. For tissue-agnostic approval, tumor mutational burden (TMB) ≥10 mut/Mb is the biomarker. Your oncologist will order the appropriate biomarker tests.
How Will I Know If Keytruda Is Working?
Imaging (CT, MRI, or PET) is typically done every 9–12 weeks to assess tumor response. Treatment continues if disease is stable or responding and side effects are tolerable. Some patients have delayed responses or ‘pseudoprogression’ (initial tumor growth followed by shrinkage) — your oncologist may continue beyond initial scans if you are clinically stable.
What Side Effects Should I Watch For?
Watch especially for immune-related adverse events: persistent or worsening diarrhea (colitis), shortness of breath or cough (pneumonitis), severe fatigue or unusual symptoms suggesting endocrine problems (thyroid, adrenal), liver dysfunction (jaundice, abdominal pain), rash, joint pain, headaches, vision changes, chest pain. Tell your oncologist promptly about any new symptoms — many immune-related events are highly treatable if caught early with corticosteroids, but can be severe if delayed.
Can I Get Keytruda Through The PAP If I Have Medicare?
Yes. Keytruda is typically billed through Medicare Part B (provider-administered IV infusion), which covers most of the cost; the PAP can help with copays or for patients without insurance.
What If My Application Is Denied?
If denied, we explore alternatives — switching to another PD-1/PD-L1 inhibitor with its own PAP (Opdivo, Tecentriq, Libtayo), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the Patient Access Network Foundation, HealthWell Foundation, Cancer Care, or Leukemia & Lymphoma Society (for blood cancer indications). If we cannot find a path, you won’t be charged our service fee.
Take Control of Your Medication Costs
If you are struggling with the high cost of Keytruda, our team may be able to help you access assistance programs designed to make brand specialty checkpoint inhibitor immunotherapy affordable. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.